June 2020

June 10, 2020

Anthony Messina published his abstract at the 2020 American Society of Clinical Oncology’s annual conference which described the emerging trends and industry utilization of patient-reported outcomes (PROs) in clinical trials of chimeric antigen receptor (CAR) T-cell therapy. 

June 10, 2020

Anthony Messina published his abstract at the 2020 American Society of Clinical Oncology’s annual conference which described the emerging trends and industry utilization of patient-reported outcomes (PROs) in clinical trials of chimeric antigen receptor (CAR) T-cell therapy.